Author(s): BROOKE HOWELL
Series: NEUROLOGY - LABORATORY AND CLINICAL RESEARCH DEVELOPMENTS
Publisher: Nova Science Publishers
Year: 2016
Language: English
Pages: 115
ALZHEIMER'S DISEASE RISK FACTORS, DIAGNOSIS, COPING AND SUPPORT......Page 3
ALZHEIMER'S DISEASE RISK FACTORS, DIAGNOSIS, COPING AND SUPPORT......Page 5
Library of Congress Cataloging-in-Publication Data......Page 6
CONTENTS......Page 7
PREFACE......Page 9
ABSTRACT......Page 15
1. ANOSOGNOSIA IN ALZHEIMER’S DISEASE......Page 16
2.1.1. Self-Monitoring and Theory of Mind Reasoning Require Third Person Perspective-Taking......Page 17
2.1.2. Two Components of Third Person Perspective-Taking: Belief Inference and Inhibition of First Person Perspective......Page 18
2.1.3. Deficits in Belief Inference in ADD......Page 19
2.2. Deficits in Self-Updating in ADD......Page 20
3. CLINICAL EVALUATION OF ANOSOGNOSIA......Page 21
4. ANOSOGNOSIA AND BPSD......Page 23
5. THERAPEUTIC EMPATHY FOR ADD......Page 25
REFERENCES......Page 26
ABSTRACT......Page 33
INTRODUCTION......Page 34
STUDY DESIGN......Page 36
MEASURES......Page 37
STATISTICAL ANALYSIS......Page 38
RESULTS......Page 40
DISCUSSION......Page 42
CONCLUSION......Page 44
REFERENCES......Page 45
ABSTRACT......Page 49
INTRODUCTION......Page 50
Selection of Articles......Page 53
Data Analyses......Page 54
Flowchart......Page 55
Severity of Impairment......Page 59
Frequency of IADL Deficits......Page 62
DISCUSSION......Page 63
Limits......Page 65
REFERENCES......Page 66
ABSTRACT......Page 71
I. INTRODUCTION......Page 72
CCR5, C5, TAU and APOE Polymorphism Typing......Page 73
CCR5, C5 and TAU Polymorphism in Patients with Alzheimer and Healthy Individuals......Page 74
APOE Polymorphism in Patients with Alzheimer and Healthy Individuals......Page 75
Genotypes Combination: CCR5-APOE, C5-APOE and TAU-APOE......Page 76
3. Discussion......Page 77
REFERENCES......Page 79
ABSTRACT......Page 83
1. INTRODUCTION......Page 84
Patients......Page 85
Cytokine Polymorphism in Patients with Alzheimer and Healthy Individuals......Page 86
Synergism between Cytokine and APOE Polymorphisms......Page 88
4. DISCUSSION......Page 89
REFERENCES......Page 90
ABSTRACT......Page 95
INTRODUCTION......Page 96
Participants and Study Design......Page 97
RESULTS......Page 99
DISCUSSION......Page 102
CONFLICT OF INTEREST......Page 103
REFERENCES......Page 104
INDEX......Page 107
